Regulatory effects of endogenous protease inhibitors in acute lung inflammatory injury

Journal of Immunology

Volumn 162, Issue 6, 1999, Pages 3653-3662

  Gipson, Teletha S ^a,b   Bless, Nicolas M ^a   Shanley, Thomas P ^a   Crouch, Larry D ^a,b   Bleavins, Michael R ^b   Younkin, Ellen M ^a   Sarma, Vidya ^a   Gibbs, Douglas F ^a   Tefera, Wongelawit ^b   McConnell, Patrick C ^b   Mueller, William T ^b   Johnson, Kent J ^a   Ward, Peter A ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTIBODY; CHEMOKINE; GELATINASE A; GELATINASE B; IMMUNOGLOBULIN G; PROTEINASE INHIBITOR; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY AFFINITY; ANTIGEN ANTIBODY COMPLEX; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; EPITHELIUM CELL; IMMUNOREGULATION; LUNG ALVEOLUS MACROPHAGE; LUNG INJURY; LUNG LAVAGE; MALE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ACUTE DISEASE; ALVEOLITIS, EXTRINSIC ALLERGIC; AMINO ACID SEQUENCE; ANIMALS; ANTIGEN-ANTIBODY COMPLEX; BASE SEQUENCE; BRONCHOALVEOLAR LAVAGE FLUID; CHEMOKINES; CHEMOTAXIS, LEUKOCYTE; CLONING, MOLECULAR; COMPLEMENT C5A; IMMUNE SERA; IMMUNOGLOBULIN G; LUNG; MALE; METALLOENDOPEPTIDASES; MOLECULAR SEQUENCE DATA; PROTEIN BIOSYNTHESIS; PROTEINASE INHIBITORY PROTEINS, SECRETORY; PROTEINS; RATS; RATS, LONG-EVANS; RNA, MESSENGER; SECRETORY LEUKOCYTE PEPTIDASE INHIBITOR; SERINE PROTEINASE INHIBITORS; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033559529     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Matrisian, L. M. 1990. Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet. 6:121.
2. Blavier, L., and Y. A. DeClerck. 1997. Tissue inhibitor of metalloproteinases-2 is expressed in the interstitial matrix in adult mouse organs and during embryonic development. Mol. Biol. Cell. 8:1513.
3. Weiss, S. J. 1989. Tissue destruction by neutrophils. N. Engl. Med. 320:365.
4. Shapiro, S. D., D. K. Kobayashi, and H. G. Welgus. 1992. Identification of TIMP-2 in human alveolar macrophages: regulation of biosynthesis is opposite to that of metalloproteinases and TIMP-1. J. Biol. Chem. 267:13890.
5. Murphy, G., T. E. Cawston, and J. J. Reynolds. 1981. Inhibitor of collagenase from human amniotic fluid: purification, characterization and action on metalloproteinases. Biochem. J. 195:167.
6. Bunning, R. A. D., G. Murphy, S. Kumar, P. Phillips, and J. J. Reynolds. 1984. Metalloproteinase inhibitors from bovine cartilage and body fluids. Eur. J. Biochem. 139:75.
7. Boone, T., M. J. Johnson, Y. A. DeClerck, and K. E. Langley. 1990. cDNA cloning and expression of a metalloproteinase inhibitor related to tissue inhibitor of metalloproteinases. Proc. Natl. Acad. Sci. USA 87:2800.
8. Silbiger, S. M., V. L. Jacobsen, R. L. Cupples, and R. A. Koski. 1994. Cloning of cDNAs encoding human TIMP-3, a novel member of the tissue inhibitor of metalloproteinase family. Gene 141:293.
9. Kleiner, D. R., Jr., E. J. Unsworth, H. C. Krutzch, and W. G. Stetler-Stevenson. 1992. Higher order complex formation between the 72-kilodalton type IV collagenase and tissue inhibitor of metalloproteinases-2. Biochemistry 31:1665.
10. DeClerck, Y. A., T. D. Yean, B. J. Ratzkin, H. S. Lu, and K. E. Langley. 1989. Purification and characterization of two related but distinct metalloproteinase inhibitors secreted by bovine aortic endothelial cells. J. Biol. Chem. 264:17445.
11. Stetler-Stevenson, W. G., H. C. Krutzsch, and L. A. Liotta. 1989. Tissue inhibitor of metalloproteinase (TIMP-2): a new member of the metalloproteinase inhibitor family. J. Biol. Chem. 264:17374.
12. Shimizu, S., K. Malik, H. Sejima, K. Kishi, T. Hayakawa, and O. Koiwai. 1992. Cloning and sequencing of cDNA encoding a mouse tissue inhibitor of metalloproteinase-2. Gene 114:291.
13. Cook, T. F., J. S. Burke, K. D. Bergman, C. O. Quinn, J. J. Jeffrey, and N. C. Partridge. 1994. Cloning and regulation of rat tissue inhibitor of metalloproteinases-2 in osteoblastic cells. Arch. Biochem. Biophys. 311:313.
14. Santoro, M., C. Battaglia, L. Zhang, F. Carlomagno, M. L. Martelli, D. Salvatore. and A. Fusco. 1994. Cloning of the rat tissue inhibitor of metalloproteinases type 2 (TIMP-2) gene: analysis of its expression in normal and transformed thyroid cells. Exp. Cell Res. 213:398.
15. Thompson, R. C., and K. Ohlsson. 1986. Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase. Proc. Natl. Acad. Sci. USA 83:6692.
16. Stetler, G., M. T. Brewer, and R. C. Thompson. 1986. Isolation and sequence of a human gene encoding a potent inhibitor of leukocyte proteases. Nucleic Acids Res. 14:7883.
17. Jin, F., C. Nathan, D. Radzioch and A. Ding. 1997. Secretory leukocyte protease inhibitor: a macrophage product induced by and antagonistic to bacterial lipopolysaccharide. Cell 88:417.
18. Zitnik, R. J., J. Zhang, M. A. Kashem, T. Kohno, D. E. Lyons, C. D. Wright, E. Rosen, I. Goldberg, and A. C. Hayday. 1997. The cloning and characterization of a murine secretory leukocyte protease inhibitor cDNA. Biochem. Biophys. Res. Commun. 232:687.
19. Hutchison, D. C. 1987. The role of proteases and antiproteases in bronchial secretions. Eur. J. Respir. Dis. 153(Suppl.):78.
20. Jacoby, A. S., J. Melrose, B. G. Robinson, V. J. Hyland, and P. Ghosh. 1993. Secretory leucocyte proteinase inhibitor is produced by human articular cartilage chondrocytes and intervetebral disc fibrochondrocytes. Eur. J. Biohem. 218:951.
21. Van Seuningen, I., J. P. Audie, B. Gosselin, J. J. Lafitte, and M. Davril. 1995. Expression of human mucous proteinase inhibitor in respiratory tract: a study by in situ hybridization. J. Histochem. Cytochem. 43:645.
22. Franken, C. J., L. M. Meijer, and J. H. Dijkman. 1989. Tissue distribution of antileukoprotease and lysozyme in humans. J. Histochem. Cytochem. 37:493.
23. Kramps, J. A., A. H. T. te Boerkhorst, J. A. M. Franson, L. A. Ginsel, and J. H. Dijkman. 1989. Antileukoprotease is associated with elastin fibers in the extracellular matrix of the human lung. Am. Rev. Respir. Dis. 140:471.
24. McElvaney, N. G., and R. G. Crystal. 1997. Antiproteases and lung defense. In The Lung: Scientific Foundations, Vol. 2. R. G. Crystal, J. B. West, E. R. Weibel, and P. J. Barnes, eds. Lippincott-Raven, New York, pp. 2219-2236.
25. McNeely, T. B., M. Dealy, D. J. Dripps, J. M. Orenstein, S. P. Eisenberg, and S. M. Wahl. 1995. Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro. J. Clin. Invest. 96:456.
26. McElvaney, N. G., and R. G. Crystal. 1997. Proteases and lung injury. In The Lung: Scientific Foundations, Vol. 2. R. G. Crystal, J. B. West, E. R. Weibel, and P. J. Barnes, eds. Lippincott-Raven, New York, pp. 2205-2218.
27. Lucey, E. C., P. J. Stone, and G. L. Snider. 1997. Consequences of proteolytic injury. In The Lung: Scientific Foundations, Vol. 2. R. G. Crystal, J. B. West, E. R. Weibel, and P. J. Barnes, eds. Lippincott-Raven, New York, pp. 2237-2250.
28. Riley, D. J., R. A. Berg, R. A. Soltys, J. S. Kerr, H. N. Guss, S. F. Curran, and D. L. Laskin. 1988. Neutrophil response following intratracheal instillation of collagen peptides into rat lungs. Exp. Lung Res. 14:549.
29. Nowak, D., I. Glowczynska, and G. Piasecka. 1989. Chemotactic activity of elastin-derived peptides for human polymorphonuclear leukocytes and their effect on hydrogen peroxide and myloperoxidase release. Arch. Immunol. Ther. Exp. Warz. 37:741.
30. Laskin, D. L., T. Kimura, S. Sakakibara, D. J. Riley, and R. A. Berg. 1986. Chemotactic activity of collagen-like polypeptides for human peripheral blood neutrophils. J. Leukocyte Biol. 39:255.
31. Mulligan, M. S., P. E. Desrochers, A. M. Chinnaiyan, D. F. Gibbs, J. Varani, J. J. Johnson, and S. J. Weiss. 1993. In vivo suppression of immune complex-induced alveolitis by secretory leukoproteinase inhibitor and tissue inhibitor of metalloproteinases-2. Proc. Natl. Acad. Sci. USA 90:11523.
32. Lucey, E. C., P. J. Stone, D. E. Ciccolella, R. Breuer, T. G. Christensen, R. C. Thompson, and G. L. Snider. 1990. Recombinant human secretory leukocyte-protease inhibitor: in vitro properties, and amelioration of human neutrophil elastase-induced emphysema and secretory cell metaplasia in the hamster. J. Lab. Clin. Med. 115:224.
33. Mulligan, M. S., and P. A. Ward. 1992. Immune-complex-induced lung and dermal vascular injury: differing requirements for requirements for TNF-α and IL-1. J. Immunol. 149:331.
34. Warren, J. S., K. R. Yabroff, D. G. Remick, S. L. Kunkel, S. W. Chensue, R. G. Kunkel, K. J. Johnson, and P. A. Ward. 1989. Tumor necrosis factor participates in the pathogenesis of acute immune complex alveolitis in the rat. J. Clin. Invest. 84:1873.
35. Negro, A., M. Onisto, L. Masiero, and S. Garbisa. 1995. Synthesis and refolding of human TIMP-2 from E. coli, with specific activity for MMP-2. FEBS Lett. 360:52.
36. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the bacteriophage T4. Nature 227:680.
37. Varani, J., B. Burmeister, R. G. Sitrin, S. B. Shollenberger, D. R. Inman, S. E. Fligiel, D. F. Gibbs, and K. J. Johnson. 1994. Expression of serine proteinases and metalloproteinases in organ-cultured human skin: altered levels in the presence of retinoic acid and possible relationship to retinoid-induced loss of epidermal cohesion. Am. J. Pathol. 145:561.
38. Heussen, C., and Dowdle, E. B. 1980. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal. Biochem. 102:196.
39. Shanley, T. P., H. Schmal, R. L. Warner, L. Schmid, H. P. Friedl, and P. A. Ward. 1997. Requirement for C-X-C chemokines (macrophage inflammatory protein-2 and cytokine-induced neutrophil chemoattractant) in IgG immune complex-induced lung injury. J. Immunol. 158:3439.
40. Mulligan, M. S., E. Schmid, B. Schimmer, G. O. Till, H. P. Friedl, R. B. Brauer, T. E. Hugli, M. Miyasaka, R. L. Warner, K. J. Johnson, et al. 1996. Requirement and role of C5a in acute lung inflammatory injury in rats. J. Clin. Invest. 98:503.
41. Hammani, K., A. Blakis, D. Morsette, A. M. Bowcock, C. Schmutte, P. Henriet, and Y. A. DeClerck. 1996. Structure and characterization of the human tissue inhibitor of metalloproteinases-2 gene. J. Biol. Chem. 271:25498.
42. Weiss, S. J., J. T. Curnutte, and S. Regiani. 1986. Neutrophil-mediated solubilization of the sub-endothelial matrix: oxidative and non-oxidative mechanisms of proteolysis used by normal and chronic granulomatous diseases phagocytes. J. Immunol. 136:636.
43. Campbell, E. J., and M. A. Campbell. 1988. Pericellular proteolysis by neutrophils in the presence of proteinase inhibitors: effects of substrate opsonization. J. Cell Biol. 106:667.
44. Mauviel, A. 1993. Cytokine regulation of metalloproteinase gene expression. J. Cell Biochem. 53:288.
45. Ito, A., H. Goskowaki, T. Sato, Y. Mori, K. Yamashita, T. Hayakawa, and H. Nagase. 1988. Human recombinant interleukin-1-α mediated stimulation of procollagenase production and suppression of biosynthesis of tissue inhibitor of metalloproteinases in rabbit uterine cervical fibroblasts. FEBS Lett. 234:326.
46. Shingu, M., Y. Nagai, T. Isayama, T. Naono, M. Nobunaga, and Y. Nagai. 1993. The effects of cytokines on metalloproteinase inhibitors (TIMP) and collagenase production by human chondrocytes and TIMP production by synovial cells and endothelial cells. Clin. Exp. Immunol. 94:145.
47. Kramps, J. A., L. N. A. Willems, C. Franken, and J. H. Dijkman. 1988. Antileukoprotease: its role in the human lung. Biol. Chem. Hoppe-Seyler 369(Suppl.): 83.
48. Sallenave, J. M., J. Shulmann, J. Crossley, M. Jordana, and J. Gauldie. 1994. Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes. Am. J. Respir. Cell Mol. Biol. 11:733.
49. Yu, M., H. Sato, M. Seiki, and E. W. Thompson. 1995. Complex regulation of membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation by concanavalin A in MDA-MB-231 human breast cancer cells. Cancer Res. 55:3272.
50. Takino, T., H. Sato, A. Shinagawa, and M. Seiki. 1995. Identification of the second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library: MT-MMPs form an unique membrane-type subclass in the MMP family. J. Biol. Chem. 270:23013.
51. Emmert-Buck, M. R., M. J. Roth, Z. Zhuang, E. Campo, J. Rozhin, B. F. Sloane, L. A. Liotta, and W. G. Stetler-Stevenson. 1995. Increased gelatinase A (MMP-2) and cathepsin B activity in invasive tumor regions of human colon cancer samples. Am. J. Pathol. 145:1285.
52. Cockett, M. I., M. L. Birch, G. Murphy, I. R. Hart, and A. J. P. Docherty. 1994. Metalloproteinase domain structure, cellular invasion and metastasis. Biochem. Soc. Trans. 22:55.
53. Abbinante-Nissen, J. M., L. G. Simpson, and G. D. Leikauf. 1993. Neutrophil elastase increases secretory leukocyte protease inhibitor transcript levels in airway epithelial cells. Am. J. Physiol. 265:L286.
54. Mitsubishi, H., S. Asano, T. Nonaka, I. Hamamura, K. I. Masuda, and M. Kiyoki. 1996. Administration of truncated secretory leukoprotease inhibitor ameliorates bleomycin-induced pulmonary fibrosis in hamsters. Am. J. Respir. Crit. Care Med. 153:369.
55. Rudolphus, A., J. A. Kramps, I. Mauve, and J. H. Dijkman. 1994. Intratracheally-instilled antileukoprotease and a1-proteinase inhibitor: effect on human neutrophil elastase-induced experimental emphysema and pulmonary localization. Histochem. J. 26:817.
56. Rudolphus, A., J. Stolk, J. H. Dijkman, and J. A. Kramps. 1993. Inhibition of lipopolysaccharide-induced pulmonary emphysema by intratracheally instilled recombinant secretory leukocyte proteinase inhibitor. Am. Rev. Respir. Dis. 147: 442.
57. Birrer, P., N. G. McElvaney, A. Gillissen, R. F. Hoyt, D. C. Bloedow, R. C. Hubbard, and R. G. Crystal. 1992. Intravenous recombinant secretory leukoprotease inhibitor augments antineutrophil elastase defense. J. Appl. Physiol. 73:317.
58. 2, and matrix metalloproteinases. J. Clin. Invest. 99:894.
59. Kleiner, D. E., E. J. Unsworth, H. C. Krutzsch, and W. G. Stetler-Stevenson. 1992. Higher-order complex formation between the 72-kilodalton type IV collagenase and tissue inhibitor of metalloproteinases-2. Biochemistry 31:1665.
60. 2-macroglobulin-bound elastase. Arch. Biochem. Biophys. 260:400.
61. Ward, P. A., and Hill, J. H. 1970. C5 chemotactic fragments produced by an enzyme in lysosomal granules of neutrophils. J. Immunol. 104:535.